Found: 9
Select item for more details and to access through your institution.
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1216, doi. 10.1111/dom.14686
- By:
- Publication type:
- Article
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 271, doi. 10.1007/s40261-024-01354-2
- By:
- Publication type:
- Article
Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 5, p. 1475, doi. 10.1007/s13300-021-01053-7
- By:
- Publication type:
- Article
Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis.
- Published in:
- ClinicoEconomics & Outcomes Research, 2020, v. 12, p. 555, doi. 10.2147/CEOR.S266873
- By:
- Publication type:
- Article
1271-PUB: Real-World Effectiveness of Newly Initiated Once-Weekly Semaglutide (sema OW) by Prescriber Specialty.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1271-PUB
- By:
- Publication type:
- Article
683-P: Real-World Evaluation of Once-Weekly Semaglutide (Sema OW) in Patients Newly Initiating GLP-1 Agonist Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-683-P
- By:
- Publication type:
- Article
652-P: Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-652-P
- By:
- Publication type:
- Article
653-P: Evaluating Antidiabetic Medication Treatment Patterns in T2D Patients Initiating Once-Weekly Semaglutide (sema OW).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-653-P
- By:
- Publication type:
- Article
953-P: Real-World Effectiveness of Once-Weekly Semaglutide (Sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-953-P
- By:
- Publication type:
- Article